ARCHIVES

NCI Reportedly Gets $691 Million From House, Senate Conferees

This article is from The Cancer Letter archive.

Vol. 01 No. 35 | October 4, 1974

Download PDF Visit The Full Archive

Related Articles

In Brief: Bailes Succeeds Lichor As ASCO President; Einhorn Is President-Elect; Durant Honored

May 21, 1999

Calcitrol+Docetaxel Prolongs Survival In Prostate Cancer

June 24, 2005

FDA News: ODAC Recommends Taxol For KS; Votes Against 2 Other Drugs

July 4, 1997

BMT Ok For some Stage IV Breast Cancer, Blues Advisor Say

March 8, 1996

FDA Approves New Toxicology Protocol; Drug Program Under Fire; DCT Board Approves Cutbacks, Contract Concepts

October 9, 1981

NIH Considering Intramural NRSA, NCI Advisors Not Enthusiastic

February 17, 1984